Why Is Psyence Biomedical (PBM) Stock Up 90% Today?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
With Psyence Biomedical moving into a Phase 2B trial, the credibility boost for its psychedelics-based drug lifted PBM stock.
The post Why Is Psyence Biomedical (PBM) Stock Up 90% Today? appeared first on InvestorPlace.
More From InvestorPlace